System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Paul Milliez is an expert in Cardiology at Centre Hospitalier Universitaire de Caen (France). Paul Milliez has authored 231 publications, the most recent in 2026, and is an investigator in 15 clinical trials, 3 of them ongoing. SLR score: 757 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Paul Milliez Centre Hospitalier Universitaire de Caen France
757 ScienceLeadR Reputation 757

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Biochemistry - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2002 - 2026
Source: PubMed

Centre Hospitalier Universitaire de Caen

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 231

Citations

Citations: 6 075 1st author: 14 Last author: 51 Unique author: 5

Main journals

Arch Cardiovasc Dis 18
Europace 16
Eur Heart J 13
Archives of Cardiovascular Diseases Supplements 12
Arch Mal Coeur Vaiss 11

Best Journals

Eur Heart J 5
Circulation 1
JAMA Oncol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Twelve-month outcomes of cavotricuspid isthmus ablation using a pentaspline pulsed field ablation catheter.
PMID 41997384 — arrhythmias, cardiac, atrial fibrillation, catheter ablation, catheters, pulsed field ablation		Heart Rhythm20260
Identification of immunomodulators associated with atrial fibrillation reporting to better understand AF immunologic mechanisms: a Vigibase retrospective disproportionality analysis and a literature review.
PMID 41946548 — cells, safety, pharmaceutical preparations, atrial fibrillation, immune system, interleukin-11		BMJ Open20260
The HONEST Cohort Study: Rationale and Design of a Nationwide Subcutaneous Implantable Cardioverter-Defibrillator Cohort.
PMID 41906608 — death, sudden, mortality, monitoring, ambulatory, hospitalization, cohort studies, defibrillators, implantable, defibrillators		JACC Adv20260
Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices: A Prospective Randomized Study.
PMID 41562534 — skin, povidone, antisepsis, chlorhexidine, cardiology, alcoholics, solutions, cardiac resynchronization therapy, risk factors, therapeutics, povidone-iodine, infections		J Am Coll Cardiol20261
Temporal trends in atrial fibrillation catheter ablation efficacy: A systematic review, meta-analysis and meta-regression from more than 20years of clinical data.
PMID 41365742 — confidence intervals, cardiovascular diseases, atrial fibrillation, catheter ablation, catheters		Arch Cardiovasc Dis20250

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

N/A 13
Phase 3 1
Phase 4 1

By status:

Completed 6
Recruiting 3
Unknown 3
Active not recruiting 1
Not yet recruiting 1
Terminated 1

By type:

Observational 10
Interventional 5

By Monocentric/Multicentric:

monocentric 11
multicentric2to4 2
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

3 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Sudden Cardiac Arrest Related to Sport in Young and Value of the Genetic Assessment a French Prospective Register
NCT06642168 — death, sudden, heart diseases, heart arrest, toxicology, diagnosis, death, sudden, cardiac, exome, exome sequencing, athletes, mutation, sports, autopsy		N/ARecruiting2024
Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B cell Malignancies
NCT06561243 — cells, cardiovascular diseases, neoplasms, atrial fibrillation, b-lymphocytes		N/AActive not recruiting2024
Is Ibrutinib related Atrial Fibrillation Dose Dependent
NCT06224452 — cells, hematologic neoplasms, neoplasms, atrial fibrillation, pharmacovigilance		N/ANot yet recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS